The HIV pandemic has been a burden for most developing countries, Kenya is not left out and advanced research has been ongoing for decades. The most recent research in the fight against the monster seem to have reached Kenya. This is after the country received the first consignment of the strawberry flavoured antiregeovirals.
Going under the brand name Dolutegravir dtg is said to be a greater milestone towards making many children and youths who are living positively join in the fight towards putting many under the therapy.
The new drugs is being advicated for by medical personnel as it has the best drug to drug interaction compared to the other medications. It is also said to show good compliance with the body , low toxicity levels and high potency. The drug is a breakthrough in the medical field as it will encourage drug intake among those infected. Continued research is currently ongoing in leading institutions all over the world and results for a vaccine are expected soon.
Content created and supplied by: Kenyahub (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More